Douglas Ross
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Douglas Ross
Insight Molecular Diagnostics Inc. reported in an 8-K filed December 21, 2022 that Douglas Ross resigned as Board, effective December 16, 2022. Insight Molecular Diagnostics Inc. reported in an 8-K filed December 21, 2022 that Douglas Ross was terminated as Chief Scientific Officer, effective December 16, 2022. The proxy statement of Insight Molecular Diagnostics Inc. reports total compensation of $1,148,649 for Douglas Ross in fiscal 2022, including a base salary of $359,135. Disclosed compensation is on record for 3 fiscal years.
“Employee acknowledges and agrees that as of Employee's Termination Date Employee will automatically be deemed to have resigned from the Board and from any and all other positions and/or titles with the Company and agrees to execute any and all documentation the Company requests to effectuate the foregoing.”
“On December 16, 2022, Oncocyte issued a press release announcing its C-suite has been restructured and the positions occupied by Gisela Paulsen, President and Chief Operating Officer, and Douglas Ross, Chief Scientific Officer, will be eliminated.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Insight Molecular Diagnostics Inc. (IMDX)
Proxy statement
Start not stated–2022-12-16
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Insight Molecular Diagnostics Inc. (IMDX) | Former Chief Science Officer | $359,135 | $1,148,649 |
| 2021 | Insight Molecular Diagnostics Inc. (IMDX) | Former Chief Science Officer | $375,000 | $1,640,137 |
| 2020 | Insight Molecular Diagnostics Inc. (IMDX) | Chief Science Officer | $375,000 | $980,437 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.